» Articles » PMID: 22405772

Regulation of P2X7-dependent Inflammatory Functions by P2X4 Receptor in Mouse Macrophages

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2012 Mar 13
PMID 22405772
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of the P2X7 receptor of macrophages plays an important role in inflammation. We recently reported that co-expression of P2X4 receptor with P2X7 receptor facilitates P2X7 receptor-mediated cell death via Ca(2+) influx. However, it remained unclear whether P2X4 receptor is involved in P2X7 receptor-mediated inflammatory responses, such as cytokine production. Here, we present evidence that P2X4 receptor modulates P2X7 receptor-dependent inflammatory functions. Treatment of mouse macrophage RAW264.7 cells with 1mM ATP induced high mobility group box 1 (HMGB1) release and IL-1β production via activation of P2X7 receptor. Knockdown of P2X4 receptor or removal of extracellular Ca(2+) suppressed ATP-induced release of both HMGB1 and IL-1β. On the other hand, knockdown of P2X4 receptor or removal of extracellular Ca(2+) enhanced P2X7-dependent LC3-II expression (an index of autophagy), suggesting that P2X4 receptor suppresses P2X7-mediated autophagy. Since LC3-II expression was inhibited by pretreatment with antioxidant and NADPH oxidase inhibitor, we examined P2X7-mediated production of reactive oxygen species (ROS). We found that activation of P2X7 receptor-mediated production of ROS was significantly facilitated in P2X4-knockdown cells, suggesting that co-expression of P2X4 receptor with P2X7 receptor may suppress anti-inflammatory function-related autophagy via suppression of ROS production. We conclude that co-expression of P2X4 receptor with P2X7 receptor enhances P2X7-mediated inflammation through both facilitation of release of cytokines and suppression of autophagy.

Citing Articles

Different localization of P2X4 and P2X7 receptors in native mouse lung - lack of evidence for a direct P2X4-P2X7 receptor interaction.

Sierra-Marquez J, Schaller L, Sassenbach L, Ramirez-Fernandez A, Alt P, Rissiek B Front Immunol. 2024; 15:1425938.

PMID: 38953020 PMC: 11215518. DOI: 10.3389/fimmu.2024.1425938.


Corrigendum: Purinergic signaling systems across comparative models of spinal cord injury.

Neural Regen Res. 2022; 18(3):689-696.

PMID: 36018196 PMC: 9727416. DOI: 10.4103/1673-5374.350234.


Physiologic roles of P2 receptors in leukocytes.

Alberto A, da Silva Ferreira N, Bonavita A, Nihei O, Farias F, Bisaggio R J Leukoc Biol. 2022; 112(5):983-1012.

PMID: 35837975 PMC: 9796137. DOI: 10.1002/JLB.2RU0421-226RR.


Purinergic signaling systems across comparative models of spinal cord injury.

Stefanova E, Scott A Neural Regen Res. 2022; 17(11):2391-2398.

PMID: 35535876 PMC: 9120689. DOI: 10.4103/1673-5374.338993.


Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.

DAntongiovanni V, Pellegrini C, Benvenuti L, Fornai M, Di Salvo C, Natale G Inflammation. 2022; 45(4):1829-1847.

PMID: 35338432 PMC: 9197920. DOI: 10.1007/s10753-022-01663-8.